Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Gee

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Blood|April 23, 2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneXiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.
Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical EffectsSpyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, et al.
Cytotherapy|January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trialsJacques Galipeau, Mauro Krampera, John Barrett, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Blood|April 23, 2014
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneXiaoou Zhou, Antonio Di Stasi, Siok-Keen Tey, et al.
Blood|December 3, 2020
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplantPremal D Lulla, Swati Naik, Spyridoula Vasileiou, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.
Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical EffectsSpyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, et al.
Cytotherapy|January 3, 2016
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trialsJacques Galipeau, Mauro Krampera, John Barrett, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Blood|September 14, 2013
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 studyConrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, et al.
Pageof 9